Kung‐Kai Kuo

2.0k total citations
70 papers, 1.5k citations indexed

About

Kung‐Kai Kuo is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kung‐Kai Kuo has authored 70 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Surgery, 25 papers in Molecular Biology and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kung‐Kai Kuo's work include Gallbladder and Bile Duct Disorders (12 papers), Pediatric Hepatobiliary Diseases and Treatments (7 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers). Kung‐Kai Kuo is often cited by papers focused on Gallbladder and Bile Duct Disorders (12 papers), Pediatric Hepatobiliary Diseases and Treatments (7 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers). Kung‐Kai Kuo collaborates with scholars based in Taiwan, Japan and United States. Kung‐Kai Kuo's co-authors include Pi‐Jung Hsiao, King‐Teh Lee, Kuang‐Hung Cheng, Shih‐Chang Chuang, Wen‐Tsan Chang, Pai‐Ching Sheen, Tzu‐Lei Kuo, Shyi‐Jang Shin, Ming‐Lung Yu and Shen‐Nien Wang and has published in prestigious journals such as PLoS ONE, Hepatology and Scientific Reports.

In The Last Decade

Kung‐Kai Kuo

69 papers receiving 1.4k citations

Peers

Kung‐Kai Kuo
Yuqin Yao China
In Hee Kim South Korea
Kevin West United Kingdom
Kung‐Kai Kuo
Citations per year, relative to Kung‐Kai Kuo Kung‐Kai Kuo (= 1×) peers Maria Franzini

Countries citing papers authored by Kung‐Kai Kuo

Since Specialization
Citations

This map shows the geographic impact of Kung‐Kai Kuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kung‐Kai Kuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kung‐Kai Kuo more than expected).

Fields of papers citing papers by Kung‐Kai Kuo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kung‐Kai Kuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kung‐Kai Kuo. The network helps show where Kung‐Kai Kuo may publish in the future.

Co-authorship network of co-authors of Kung‐Kai Kuo

This figure shows the co-authorship network connecting the top 25 collaborators of Kung‐Kai Kuo. A scholar is included among the top collaborators of Kung‐Kai Kuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kung‐Kai Kuo. Kung‐Kai Kuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Deng‐Chyang, Chia‐Chen Ku, Jia-Bin Pan, et al.. (2023). Heterogeneity of Phase II Enzyme Ligands on Controlling the Progression of Human Gastric Cancer Organoids as Stem Cell Therapy Model. International Journal of Molecular Sciences. 24(21). 15911–15911. 5 indexed citations
2.
Kuo, Kung‐Kai, Shih‐Chang Chuang, Shen‐Nien Wang, et al.. (2022). Single-incision versus four-incision laparoscopic transfistulous bile duct exploration for Mirizzi syndrome type II. Surgical Endoscopy. 36(11). 8672–8683. 4 indexed citations
3.
Kuo, Kung‐Kai, Pi‐Jung Hsiao, Wen‐Tsan Chang, et al.. (2021). Therapeutic Strategies Targeting Tumor Suppressor Genes in Pancreatic Cancer. Cancers. 13(15). 3920–3920. 10 indexed citations
4.
Chuang, Shih‐Chang, Yu-Chu Wang, Jian‐Wei Huang, et al.. (2020). Expression of FOXM1 and Aurora-A predicts prognosis and sorafenib efficacy in patients with hepatocellular carcinoma. Cancer Biomarkers. 28(3). 341–350. 10 indexed citations
5.
Saito, Shigeo, Ying‐Chu Lin, Yukio Nakamura, et al.. (2018). Potential application of cell reprogramming techniques for cancer research. Cellular and Molecular Life Sciences. 76(1). 45–65. 28 indexed citations
6.
Wu, Bin‐Nan, Kung‐Kai Kuo, Hung‐Tu Huang, et al.. (2016). Theophylline-Based KMUP-1 Improves Steatohepatitis via MMP-9/IL-10 and Lipolysis via HSL/p-HSL in Obese Mice. International Journal of Molecular Sciences. 17(8). 1345–1345. 11 indexed citations
7.
Chang, Wen‐Tsan, Yu‐Ting Kuo, King‐Teh Lee, et al.. (2016). The value of primary vascular stents in management of early portal vein stenosis after liver transplantation. The Kaohsiung Journal of Medical Sciences. 32(3). 128–134. 9 indexed citations
8.
Kuo, Kung‐Kai, Pi‐Jung Hsiao, Yu‐Wen Chen, et al.. (2015). Pancreatic Tumor Progression Associated With CD133 Overexpression. Pancreas. 45(3). 443–457. 23 indexed citations
9.
Kuo, Kung‐Kai, Shih‐Shin Liang, Chun‐Hao Huang, et al.. (2015). Quantitative Proteomic Analysis of Differentially Expressed Protein Profiles Involved in Pancreatic Ductal Adenocarcinoma. Pancreas. 45(1). 71–83. 16 indexed citations
10.
Chou, Yu‐Wei, Gopal Chandru Senadi, Chung‐Yu Chen, et al.. (2015). Design and synthesis of pyrrolobenzodiazepine-gallic hybrid agents as p53-dependent and -independent apoptogenic signaling in melanoma cells. European Journal of Medicinal Chemistry. 109. 59–74. 11 indexed citations
11.
Chen, Yuwen, Pi‐Jung Hsiao, Kung‐Kai Kuo, et al.. (2014). SMAD4 Loss triggers the phenotypic changes of pancreatic ductal adenocarcinoma cells. BMC Cancer. 14(1). 181–181. 54 indexed citations
12.
Hsiao, Pi‐Jung, Lihua Chen, Tzu‐Lei Kuo, et al.. (2013). Stem Cell Marker Nestin Is Critical for TGF-β1-Mediated Tumor Progression in Pancreatic Cancer. Molecular Cancer Research. 11(7). 768–779. 70 indexed citations
13.
Hsiao, Pi‐Jung, et al.. (2013). Inorganic arsenic trioxide induces gap junction loss in association with the downregulation of connexin43 and E‐cadherin in rat hepatic “stem‐like” cells. The Kaohsiung Journal of Medical Sciences. 30(2). 57–67. 13 indexed citations
14.
Vandavasi, Jaya Kishore, et al.. (2013). A convenient method to construct (Z)-oxazines via 6-exo-dig iodocyclization and synthesis of indolin-3-one. Organic & Biomolecular Chemistry. 11(38). 6520–6520. 22 indexed citations
15.
Kuo, Kung‐Kai, et al.. (2012). The Activation of MEK/ERK Signaling Pathway by Bone Morphogenetic Protein 4 to Increase Hepatocellular Carcinoma Cell Proliferation and Migration. Molecular Cancer Research. 10(3). 415–427. 61 indexed citations
16.
Chuang, Shih‐Chang, Shen‐Nien Wang, Wen‐Tsan Chang, et al.. (2012). Natural course of splenic artery aneurysm with associated spontaneous splenorenal shunt in non‐cirrhotic liver: An 18‐year observational follow‐up and review of literature. The Kaohsiung Journal of Medical Sciences. 29(1). 55–58. 5 indexed citations
17.
Cheng, Kuang‐Hung, Tzu‐Lei Kuo, Kung‐Kai Kuo, & Chang‐Chun Hsiao. (2011). Human adipose-derived stem cells: Isolation, characterization and current application in regeneration medicine. 3(2). 53–62. 44 indexed citations
18.
Chuang, Shih‐Chang, et al.. (2006). Hypertriglyceridemia-associated Acute Pancreatitis with Chylous Ascites in Pregnancy. Journal of the Formosan Medical Association. 105(7). 583–587. 15 indexed citations
19.
Wang, Shen‐Nien, et al.. (2006). Aberrant P53 Expression and the Development of Gallbladder Carcinoma and Adenoma. The Kaohsiung Journal of Medical Sciences. 22(2). 53–59. 16 indexed citations
20.
Kuo, Kung‐Kai, Toshinaga Nabae, Shunichi Takahata, et al.. (2000). Sphincter of Oddi Motility in Patients with Hepatolithiasis and Common Bile Duct Stones. Digestive Diseases and Sciences. 45(9). 1714–1718. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026